Connect with us

Technology

Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)

Published

on

STOCKHOLM, Sept. 3, 2024 /PRNewswire/ — The shareholders of Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”), Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the extraordinary general meeting on Monday 30 September 2024 at 12:00 p.m. CEST at Advokatfirman Vinge’s premises on Smålandsgatan 20, SE-111 46, Stockholm, Sweden. Registration starts at 11:30 a.m. CEST.

Background

Asahi Kasei Corporation (“Asahi Kasei”), which has announced that the public offer made regarding the company’s shares has been accepted to such extent that Asahi Kasei becomes the owner of more than 90 per cent of the shares and votes in the company, has requested the board of directors to issue a notice to an extraordinary general meeting to address the matters that are set out in the proposed agenda. Furthermore, Asahi Kasei has informed Calliditas that the company will revert with its proposed resolutions for the requested items 7-11 on the proposed agenda in connection with the general meeting, at the latest, and will be prepared to present its proposals at the general meeting.

Right to participate in the extraordinary general meeting and notice of participation

A shareholder who wishes to participate in the general meeting must (i) be recorded as a shareholder in the share register maintained by Euroclear Sweden AB relating to the circumstances on 20 September 2024, and (ii) no later than 24 September 2024 give notice by post to Calliditas Therapeutics AB (publ), Extraordinary General Meeting 2024, c/o Euroclear Sweden, Box 191, SE-101 23 Stockholm, Sweden or via e-mail to GeneralMeetingService@euroclear.com. When providing such notice, the shareholder shall state name, personal or corporate registration number, address, telephone number and the number of any accompanying assistant(s) (maximum two assistants) as well as information about any proxy.

If a shareholder is represented by proxy, a written, dated proxy for the representative must be issued. A proxy form is available on the company’s website, www.calliditas.se. If the proxy is issued by a legal entity, a certificate of registration or equivalent certificate of authority should be enclosed. To facilitate the registration at the general meeting, the proxy and the certificate of registration or equivalent certificate of authority should be sent to the company as set out above so that it is received no later than 27 September 2024. 

Nominee-registered shares

To be entitled to participate in the general meeting, a shareholder whose shares are held in the name of a nominee must, in addition to providing notification of participation, register its shares in its own name so that the shareholder is recorded in the share register relating to the circumstances on 20 September 2024. Such registration may be temporary (so-called voting right registration) and is requested from the nominee in accordance with the nominee’s procedures and in such time in advance as the nominee determines. Voting right registrations completed by the nominee not later than 24 September 2024 are taken into account when preparing the share register.

Number of shares and votes

As of the date of this notice there are a total 54,033,447 ordinary shares outstanding in the company that entitle to one vote per share at the general meeting. Furthermore, as of the date of this notice, the company holds 5,908,018 own ordinary shares which cannot be represented at the general meeting. Thus, there are a total of 59,941,465 ordinary shares and votes in the company, of which 54,033,447 shares and votes can be represented at the general meeting.

Proposed agenda          

Opening of the meeting           Election of a chairman of the meetingPreparation and approval of the voting registerApproval of the agendaElection of one or two persons to approve the minutes           Determination of whether the meeting was duly convened         Determination of the number of board members           Election and removal of board members         Determination of fees to the board members         Resolution that the principles for appointing the nomination committee shall no longer apply after the delisting of Calliditas‘ shares from Nasdaq Stockholm         Resolution that the guidelines on remuneration to group management and board members shall no longer apply after the delisting of Calliditas’ shares from Nasdaq Stockholm           Closing of the meeting

Election of chairman of the meeting (item 2)

The nomination committee proposes that Dain Hård Nevonen is elected as chairman of the general meeting.

Shareholder’s right to obtain information

Shareholders are reminded of their right to, at the general meeting, obtain information from the board of directors and CEO in accordance with Chapter 7 Section 32 of the Companies Act. Shareholders who wish to submit questions in advance may do so by sending post to Calliditas Therapeutics AB (publ), att. Fredrik Johansson, Kungsbron 1 D5, SE-111 22 Stockholm, Sweden, or via e-mail to fredrik.johansson@calliditas.com.

Other information

Proxy forms will be available at the company’s office and on Kungsbron 1 D5, SE-111 22 Stockholm, Sweden, and on the company’s webpage, www.calliditas.se/en/ at least three weeks before the general meeting. Copies of the documents will be sent to the shareholders who so request and who states their postal address.

Processing of personal data

For information on how your personal data is processed, please see the integrity policy that is available at Euroclear’s website, https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.

Stockholm, 3 September 2024

Calliditas Therapeutics AB (publ)

The board of directors

This is an in-house translation of the Swedish original wording. In case of discrepancies between the English translation and the Swedish original, the Swedish text shall prevail.

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/calliditas-therapeutics/r/notice-of-extraordinary-meeting-of-calliditas-therapeutics-ab–publ-,c4032413

The following files are available for download:

https://mb.cision.com/Main/16574/4032413/2978573.pdf

Calliditas – EGM 2024 – Notice (eng)

 

View original content:https://www.prnewswire.com/news-releases/notice-of-extraordinary-meeting-of-calliditas-therapeutics-ab-publ-302236607.html

SOURCE Calliditas Therapeutics

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

TECNO Named Among 2024-2025 Global Top 10 Smartphone Brands and Wins Dual Product Innovation Awards at CES 2025

Published

on

By

LAS VEGAS, Jan. 9, 2025 /PRNewswire/ — TECNO, a global innovative technology brand, celebrates a landmark achievement at CES 2025. The brand earned three awards: its selection as one of the 2024-2025 Global Top 10 Smartphone Brands, marking its third consecutive win, and recognition for its groundbreaking products, the PHANTOM V Fold2 5G and Pocket Go AR Handheld Gaming Device, which claimed prestigious product innovation awards.

The annual CES Global Top Brands Award and Product Innovation Awards, celebrates global consumer electronics brands leading in frontier innovations. This prestigious platform, often referred to as the “Oscars of the Global Consumer Electronics Industry,” recognizes the brands and products that have not only made a remarkable impact on the global market, but also set new standards for technology and consumer experience across the industry.

A Legacy of Innovation and Global Impact

“This achievement is a testament to our breakthroughs and accomplishments in building an intelligent product ecosystem. Each of the awarded products embodies a distinct aspect of our brand’s innovation: from cutting-edge AI advancements to transformative user experiences. These innovations enable us to accelerate the adoption of AI and emerging technologies in key markets, ensuring that consumers in emerging markets can fully benefit from the digital revolution.” said Guo Lei, General Manager of TECNO.

In the past year, TECNO took bold strides toward its AI-powered future, introducing a series of innovations- TECNO launched the newest PHANTOM foldable series, bringing practical AI-powered features and functions that make a real difference in people’s lives. By integrating advanced AI algorithms with extensive multi-skin tone database, TECNO launched an upgraded Universal Tone technology, further takes up the challenge of solving skin tone “color bias” in smartphone imaging and formed partnerships with top global universities such as Leeds University, Nanyang Technological University in Singapore and Dar Al – Hekma University in Saudi Arabia.

“TECNO exemplifies how global innovation can resonate locally,” said Zhu Dongfang, President of the Asian Digital Group, speaking on behalf of the jury. “Its commitment to making advanced technology accessible and impactful for emerging markets not only redefines the user experience but also cements its standing as a trailblazer in smart devices and AI innovation.”

TECNO PHANTOM V Fold2 5G: Winner of the AI-Powered Foldable Phone Innovation Award

The PHANTOM V Fold2 5G received the prestigious AI-Powered Foldable Phone Innovation Award, underscoring TECNO’s determination to reshape the foldable smartphone landscape.

Combining sleek design with powerful AI capabilities, the PHANTOM V Fold2 5G is an industry standout. Its ultra-thin profile—just 5.5mm when unfolded—sets a new standard for portability without sacrificing durability, thanks to its aviation-grade waterdrop hinge. Its 7.85-inch 2K AMOLED main screen and 6.42-inch curved AMOLED outer screen deliver immersive visuals, enhanced by Dolby Atmos surround sound for a premium multimedia experience.

Powered by TECNO’s Ella AI assistant, the device seamlessly integrates features like real-time translation, intelligent writing, and productivity tools, including the PHANTOM V Pen. This makes it an ideal companion for professionals seeking to blend creativity and efficiency.

TECNO Pocket Go: Winner of the Ultra-Portable AR PC Gaming Innovation Design Award

TECNO’s Pocket Go redefines portable gaming, winning the Ultra-Portable AR PC Gaming Innovation Design Award for its visionary integration of augmented reality (AR) with handheld gaming.

Weighing just 557 grams, Pocket Go delivers the immersive quality of a 215-inch TV projection in a compact, ultra-light design. Its VisionTrack technology leverages head tracking and AI algorithms to create an unmatched sensory gaming experience.

Powered by an AMD Ryzen™ 7 processor, Pocket Go excels in performance, handling AAA gaming titles seamlessly while offering replaceable battery design, and PC-level cooling mechanisms for uninterrupted play. Beyond gaming, the device transitions effortlessly to productivity, and multimedia tasks and multi-usages, reflecting TECNO’s dedication to creating versatile technology.

With Pocket Go, TECNO merges gaming innovation with AR technology to deliver an immersive and portable experience like no other, showcasing its ability to continuously explore new frontiers in connected living, as a industry leader setting new global standards.

TECNO’s momentous achievements at the CES Global Top Brands Awards and Product Innovation Awards highlight its consistent efforts to innovate while addressing the unique needs of emerging markets. Staying true to its “Stop at Nothing”spirit, TECNO continues to enhance productivity, unleash creativity and remains resolute in its mission to bridge the digital divide and bring transformative experiences to markets.

View original content to download multimedia:https://www.prnewswire.com/news-releases/tecno-named-among-2024-2025-global-top-10-smartphone-brands-and-wins-dual-product-innovation-awards-at-ces-2025-302346808.html

SOURCE TECNO Mobile Limited

Continue Reading

Technology

Redefining Charging: Anker Innovations Showcases Smart and Sustainable Solutions at CES

Published

on

By

BELLEVUE, Wash., Jan. 9, 2025 /PRNewswire/ — Anker Innovations, a global leader in mobile charging and consumer electronics, today unveiled its latest groundbreaking charging innovations at the Consumer Electronics Show (CES), held January 7-10 in Las Vegas. Among the featured products from Anker mobile charging and Anker SOLIX are the 25,000mAh Anker Power Bank, Anker 140W Charger, EverForest 2 Electric Cooler and Solar Umbrella, redefining fast-charging standards for users worldwide.

The products mentioned above will soon be available in Southeast Asia as well. “As the world’s No.1 mobile charging brand, we are grateful for the support of Southeast Asian consumers,” said Leon Wu, Head of Anker Innovations Southeast Asia. “Our mission is to ignite possibilities through ultimate innovation, and we are committed to providing products that exceed consumer expectations in Southeast Asia.”

Anker Innovations, a global leader in fast-charging technologies, develops products for home, office, and on-the-go charging. By integrating Gallium Nitride (GaN) technology and proprietary features, Anker delivers a safer, faster, and more sustainable charging experience. The Anker Prime Charging Docking Station (14-in-1, 160W) won the CES 2025 Innovation Award in the Computer Peripherals & Accessories category.

Anker 25,000mAh Power Bank (165W, Built-In and Retractable Cables)

Small in size and packed with the latest PD 3.0 technology, Anker’s fast-charging power bank delivers powerful performance.

Looking at Anker’s 25K 165W compact power bank, it boasts an impressive 25,000mAh capacity. Equipped with three USB-C ports and one USB-A port, it is ideal for charging multiple devices on the go. It can charge a MacBook Air 13′(M3) 2024 1.3 times, an iPhone 16 up to 4.5 times, and boost a MacBook Pro 16″ (M3) battery to 50% in just 33 minutes.

Notably, Anker’s 25,000mAh 165W power bank is the world’s first high-power power bank with retractable cables. It includes a 22cm cable and a 69cm retractable cable, this provides flexible charging options for users on the move while walking, sitting, or lying down.

With its smart TFT color screen and vibrant user interface, the power bank provides real-time data, including output power, power bank temperature and estimated charging time. Users can pull the retractable cable to trigger screen animations featuring dynamic emojis, adding a new level of convenience and fun.

Anker 140W Charger featuring First-Ever Digital Display

Anker’s charger breaks new ground as the first to feature a digital window display, bringing advanced functionality to the forefront. Users can easily check the total power output, output for each port, view the remaining power in real-time, monitor temperature, and track the total operation time for a more comprehensive overview.

Real-time temperature monitoring ensures device safety, while Anker’s advanced Active Shield 2.0 technology enhances the safety and reliability with up to 3 million daily safety checks. Built with aerospace-grade GaN, the charger maximizes performance for faster and more efficient charging.

Additionally, the four-port charger (3 USB-C and 1 USB-A) boasts sleek aesthetics and wall mounting capabilities.

Anker Prime 250W GaN Desktop Charger (6 Ports)

The Anker Prime 250W GaN Desktop Charger is a powerful 6-port solution designed for modern multi-device users. With 4 USB-C ports and 2 USB-A ports, it offers up to 250W of total output, capable of charging multiple devices simultaneously, from smartphones to laptops. Its standout feature is the 140W max power delivery for MacBook Pro users, fully charging a 16″ MacBook Pro in under two hours via PD3.1 technology.

A key feature is the 2.3″ LCD display, which shows real-time power output for each port and can be turned off manually or automatically. The twist button control allows users to view port details, adjust priorities, and switch between power modes with ease. This GaN-based charger combines high power, compact design, and smart control, making it the ideal charging solution for professionals and tech enthusiasts alike.

Leading the Future of Charging Technology

Anker’s new line of high-speed USB-C chargers are available exclusively on apple.com and at select Apple Store locations worldwide, designed to meet a variety of charging needs and can efficiently charge Apple Watches, AirPods, iPhones, iPads, MacBooks, and more, making them the perfect companion for Apple devices.

As a global pioneer in charging technologies, Anker continues to push the boundaries of what’s possible. Featuring cutting-edge GaN technology, these latest products deliver faster speeds, reduced heat generation, and more compact designs compared to traditional silicon-based chargers.

More importantly, these innovations are designed with user insights in mind, transforming charging devices from cold hardware into interactive and connected ecosystems, solidifying Anker’s status as a leader in next-generation charging technology.

In the near future, Anker plans to bring its Prime series—the most advanced multi-device fast charging lineup—along with its cutting-edge innovations to more users across Southeast Asian countries.

About Anker

Anker is the world’s #1 mobile charging brand and a developer of high-speed charging technologies for the home, car, and on the go. This includes wall plugs, wireless chargers, car chargers, power banks, cables, and more. Find out more about Anker at anker.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/redefining-charging-anker-innovations-showcases-smart-and-sustainable-solutions-at-ces-302345972.html

SOURCE Anker Innovations

Continue Reading

Technology

Implantica announces new exceptional published data from the largest real-world study from Germany

Published

on

By

VADUZ, Liechtenstein, Jan. 9, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces the journal Surgery Open Science, affiliated with the prestigious journal Surgery, recently published the largest real-world study from Germany, “A retrospective study assessing RefluxStop surgery for gastroesophageal reflux disease: Clinical outcomes in 79 patients from Germany“.

This first-of-its-kind real-world study from Germany’s leading Reflux center involving 79 patients for up to 17 months follow-up was led by Priv.-Doz. Dr. Thorsten G. Lehmann, MHBA – Center Director and Chief Physician of the Clinic for General and Visceral Surgery Friedrichshafen in southern Germany.

Dr. Lehmann’s study conclusion presented medical treatment with PPI reduced from 94.9% (before surgery) to 2.5% (after surgery) at follow-up. The study results show outstanding safety and effectiveness results demonstrating significant improvements both in PPI use and in quality of life, showing median improvements in GERD-HRQL (Gastro-Esophageal Reflux Disease – Health-Related Quality-of-Life) score of 100% and mean improvements of 92.4%. These outstanding outcomes are especially encouraging as half of study participants had either large hiatal hernia, >3 cm, or reoperation for previously failed anti-reflux surgery, both groups typically experience much higher complication rates.

Founder and CEO of Implantica, Dr. Peter Forsell says, “I am always humbled by the independent surgeons who continue to choose to gather and report RefluxStop™ data. Priv.-Doz. Dr. Lehmann’s data is yet another confirmation of the fantastic results one can achieve with the RefluxStop™ treatment. Remarkable results have now been reported by many independent centers across Europe showing similar exceptional safe and effective outcomes. With more than 1000 patients treated in Europe over the past five years, this study marks yet another great milestone demonstrating RefluxStop’s potential to revolutionize the GERD treatment landscape for millions of patients around the World.”

For further information, please contact:
Nicole Pehrsson, Chief Corporate Affairs Officer
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company’s Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on January 09, 2025, at 08:30 a.m. (CET).

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

About RefluxStop™

RefluxStop™ is a new innovative treatment that has the potential to spur a paradigm shift in anti-reflux surgery. It’s unique mechanism of action differentiates it from standard of care and current surgical solutions. Longer established surgical options for GORD involve encircling the food passageway to support the lower oesophageal sphincter’s closing mechanism and are commonly associated with side effects such as swallowing difficulties, pain when swallowing and inability to belch and/or vomit.

In contrast, the RefluxStop™ device treats the cause of acid reflux without encircling and putting pressure on the food passageway. It restores and maintains the lower oesophageal sphincter in its original, natural position.

The RefluxStop™ mechanism of action is focused on reconstructing all three components of the anti-reflux barrier, that if compromised could possibly result in acid reflux. It restores and supports the natural anatomical physiology of the body allowing the body to itself solve the problem with acid reflux.

Newsroom
https://www.implantica.com/media/media-kit

Community
https://ch.linkedin.com/company/implantica
https://www.twitter.com/implantica

Media Contact:
Implantica AG
Juanita Eberhart, VP Marketing & Advocacy
M: +1 925-381-4581
juanita.eberhart@implantica.com

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/implantica/r/implantica-announces-new-exceptional-published-data-from-the-largest-real-world-study-from-germany,c4089263

The following files are available for download:

https://mb.cision.com/Main/19732/4089263/3197605.pdf

Implantica announces new exceptional published data from the largest real-world study from Germany

https://news.cision.com/implantica/i/logo-transparent-1-8,c3366854

logo transparent 1 8

https://news.cision.com/implantica/i/reluxstop-product,c3366855

ReluxStop Product

 

View original content:https://www.prnewswire.co.uk/news-releases/implantica-announces-new-exceptional-published-data-from-the-largest-real-world-study-from-germany-302346814.html

Continue Reading

Trending